发明申请
US20100029653A1 PYRAZOLOPYRIDINE, INDAZOLE, IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE, PYRAZOLOPYRAZINE AND PYRAZOLOPYRIDINE DERIVATIVES AS STIMULATORS OF GUANYLATE CYCLASE FOR CARDIOVASCULAR DISORDERS
失效
吡咯并吡啶，吲哚，咪唑吡嗪，咪唑嗪，吡唑并吡嗪和吡唑并吡啶衍生物作为冠状动脉循环中心脏血管疾病的刺激因子
- 专利标题： PYRAZOLOPYRIDINE, INDAZOLE, IMIDAZOPYRIDINE, IMIDAZOPYRIMIDINE, PYRAZOLOPYRAZINE AND PYRAZOLOPYRIDINE DERIVATIVES AS STIMULATORS OF GUANYLATE CYCLASE FOR CARDIOVASCULAR DISORDERS
- 专利标题（中）： 吡咯并吡啶，吲哚，咪唑吡嗪，咪唑嗪，吡唑并吡嗪和吡唑并吡啶衍生物作为冠状动脉循环中心脏血管疾病的刺激因子
-
申请号： US12441242申请日： 2007-09-01
-
公开(公告)号： US20100029653A1公开(公告)日： 2010-02-04
- 发明人: Hartmut Schirok , Joachim Mittendorf , Johannes-Peter Stasch , Frank Wunder , Friederike Stoll , Karl-Heinz Schlemmer
- 申请人： Hartmut Schirok , Joachim Mittendorf , Johannes-Peter Stasch , Frank Wunder , Friederike Stoll , Karl-Heinz Schlemmer
- 申请人地址： DE Berlin
- 专利权人： Bayer Schering Pharma Aktiengesellschaft
- 当前专利权人： Bayer Schering Pharma Aktiengesellschaft
- 当前专利权人地址： DE Berlin
- 优先权： DE102006043443.9 20060915
- 国际申请： PCT/EP2007/007658 WO 20070901
- 主分类号： A61K31/53
- IPC分类号： A61K31/53 ; C07D403/14 ; A61P9/00 ; A61P9/04 ; A61P9/12 ; A61P9/10 ; A61K31/519 ; C07D413/14 ; A61K31/505 ; A61K31/437
摘要：
The present application relates to novel azabicyclic compounds, processes for their preparation, their use alone or in combinations for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular disorders.
公开/授权文献
信息查询
